Syntimmune
is a biotechnology company that develops antibody therapeutics for the treatment of autoimmune diseases... Read moreSyntimmune
is a biotechnology company that develops antibody therapeutics for the treatment of autoimmune diseases... Read more
CEO
Add
News
Jun 25, 2019
FierceBiotech
Syntimmune: After being snapped up by Alexion, Syntimmune's CEO joins MorphoSys
Nov 05, 2018
Banker & Tradesman
Syntimmune: Alexion Pharmaceuticals Completes Acquisition
Nov 02, 2018
PharmiWeb
Syntimmune: Alexion Completes Acquisition of Syntimmune
Oct 03, 2018
BioPharma-Reporter
Syntimmune: Alexion continues rare disease M&A with Syntimmune acquisition
Sep 26, 2018
Reuters
Syntimmune: UPDATE 1-Alexion to buy biotech firm Syntimmune for up to $1.2 bln
Sep 12, 2018
4-traders
Syntimmune: Syntimmune Announces FDA Orphan Drug Designation for SYNT001 in Treatment of Pemphigus
Jul 09, 2018
FierceBiotech
Syntimmune: Syntimmune picks up Vertex VP for CMO as leadership changes continue
Jul 09, 2018
BioPortfolio
Syntimmune: Syntimmune Strengthens Leadership Team with Appointment of Chief Medical Officer
Jun 04, 2018
BioPortfolio
Syntimmune: Syntimmune to Present at Jefferies 2018 Global Healthcare Conference
May 17, 2018
BioPortfolio
Syntimmune: Syntimmune Announces Positive Preliminary Results from Clinical ProofofConcept Trial of SYNT001 in Pemphigus Vulgaris and Foliaceus
Syntimmune Competitors
1
2
3
4
5
6
7
8
9
10